Independent Fund Manager, Swaen Capital

Swaen Capital

Swaen Capital is a Singapore based licensed independent fund manager with an open architecture, a non bias financial platform creating access to the best custodians and investment managers.

Our focus lies within the wealth management business, covering client relationships, financial planning, advisory, as well as discretionary portfolio management.

We have developed strategic alliances with other leading independent firms to complement and extend our offerings to clients (global hedge fund research capability, alternative investment offerings, corporate finance, fund structuring & administration, etc).

Our know-how, extensive global network and long standing presence in Asia allows us to provide a global footprint and at the same time enables us to capitalize on regional opportunities.

Independent Fund Manager

Swaen Capital is a Singapore based licensed independent fund manager with an open architecture, a non bias financial platform creating access to the best custodians and investment managers. Our focus lies within the wealth management business, covering client relationships, financial planning, advisory, as well as discretionary portfolio management. We have developed strategic alliances with other leading independent firms to complement and extend our offerings to clients (global hedge fund research capability, alternative investment offerings, corporate finance, fund structuring & administration, etc). Our know-how, extensive global network and long standing presence in Asia allows us to provide a global footprint and at the same time enables us to capitalize on regional opportunities.

Equity Bottom-Up

<ul>
<li>Equipment sales tide through: MetaOptics continues to sell metalens testersto Taiwan. Contract liabilities provide revenue visibility into 2HFY26.</li>
<li>The company withdrew their dual list application at Nasdaq, but continues to expand its US presence, with their Direct Laser Writer deployments at US academic facilities assisting interested partners with prototyping and sampling.</li>
<li>Funded to execute: A flexible cost structure across development and marketing supports an extended cash runway of over 2 years to advance a broadening pipeline, including the Elsoft equipment partnership and a 12MP TiO2 metalens now prototyping for a major global tech company.</li>
</ul>


Equipment sales tide through: MetaOptics continues to sell metalens testersto Taiwan. Contract liabilities provide revenue visibility into 2HFY26.
The company withdrew their dual list application at Nasdaq, but continues to expand its US presence, with their Direct Laser Writer deployments at US academic facilities assisting interested partners with prototyping and sampling.
Funded to execute: A flexible cost structure across development and marketing supports an extended cash runway of over 2 years to advance a broadening pipeline, including the Elsoft equipment partnership and a 12MP TiO2 metalens now prototyping for a major global tech company.


MetaOptics Ltd Midyear Update (21 August 2026)